Back to AMLN Stock Lookup

AMLN Related Corporate News

Jul 10, 2012 07:33 AM Bristol-Myers Squibb (BMY) Commences $31/Share Cash Tender for Amylin (AMLN)

Jun 11, 2012 07:58 AM Amylin (AMLN) Says SYMLIN + Insulin Gives Better Blood Glicose Measurement Results in Type 1, 2 Diabetes

Jun 11, 2012 07:56 AM Amylin (AMLN), Alkermes (ALKS) Say BYDUREON Achieved Statistically Significant Glycemic Control Results in Type 2 Diabetes

Jun 11, 2012 07:54 AM Amylin Pharma (AMLN), Alkermes (ALKS) Reports Encouraging A1C Data from BYDUREON in Type 2 Diabetes

Jun 11, 2012 07:52 AM Amylin Pharma (AMLN) Says BYETTA Glycemic Control Results Better than Amaryl in Type 2 Diabetes

Apr 9, 2012 11:55 AM Icahn Files Suit Against Amylin (AMLN), Seeks Extension of Nomination Deadline

Apr 4, 2012 08:13 AM Icahn Sends Letter to Amylin (AMLN) Board; Says Company Should Be Sold

Apr 3, 2012 08:05 AM Amylin Pharma (AMLN) Completes BLA Submission to FDA for Metreleptin; Requests Priority Review

Mar 23, 2012 08:02 AM Amylin (AMLN), Lilly (LLY) Get Marketing Approval from EC for BYETTA with Basal Insulin Treatment

Mar 8, 2012 09:02 AM Amylin (AMLN) Prices 13M Offering; Sees Gross Proceeds of $203.1M

Jan 27, 2012 02:57 PM Letter from FDA Director to Amylin's (AMLN) Kolterman Discussing Bydureon Approval

Jan 9, 2012 05:07 PM Amylin (AMLN) Updates on BYDUREON, BYETTA, Other Drivers of Growth in FY12

Nov 8, 2011 06:32 AM Amylin (AMLN), Lilly (LLY) Terminate Exenatide Alliance, Resolve Litigation

Oct 20, 2011 06:53 AM Amylin (AMLN), Lilly (LLY) Get FDA Approval for BYETTA Use as Add-On to Insulin in Certain Cases

Sep 12, 2011 07:12 AM Amylin (AMLN), Alkermes (ALKS), Lilly (LLY) Report Strong Data from BYDUREON DURATION-3 and -4

Aug 10, 2011 04:20 PM Amylin (AMLN), Lilly (LLY), Alkermes (ALKS) Receive PDUFA Date for BYDUREON

Aug 5, 2011 07:26 AM Amylin (AMLN), Takeda Discontinue Pramlintide/Metreleptin Development Following Phase 2 Reassessment

Jun 27, 2011 03:43 PM Amylin (AMLN) Shares Up 7.5% Amid Byetta/Bydureon Data; CEO Says 'Very Confident' in Diabetes Treatments

Jun 21, 2011 06:31 AM BYDUREON Receives Marketing Authorization in Europe (LLY) (ALKS) (AMLN)

May 26, 2011 06:52 AM Amylin (AMLN) Reports Temp. Restraining Order Issued Against Lilly (LLY)

May 16, 2011 06:55 AM Amylin (AMLN) Sues Eli Lilly (LLY) Over Exenatide Agreements

Mar 16, 2011 08:06 AM Amylin (AMLN), Takeda Suspend Obesity Treatment Trial; Amylin Lower Pre-Market

Dec 22, 2010 04:18 PM Amylin Pharma (AMLN), Lilly (LLY) File sNDA with U.S. FDA for Expanded BYETTA Use

Jun 18, 2010 11:28 AM Roche's Taspoglutide Setback Gives Amylin (AMLN) A Boost

Jun 15, 2010 08:27 AM Amylin Pharma (AMLN), Eli Lilly (LLY), and Alkermes (ALKS) Announce Results of DURATION-4 for BYDUREON

Jun 14, 2010 10:05 AM Asterand Subsidiary Signs One-Year Collaboration Agreement with Amylin Pharma (AMLN)

Apr 22, 2010 05:03 PM Amylin Pharma (AMLN), Lilly (ELY), and Alkermes (ALKS) Submit Replies to U.S. FDA Complete Response for BYDUREON

Jan 11, 2010 08:21 AM BioCentury Publishes BioTech Picks for FY10 (HGSI, VRTX, AMGN, More...)

Dec 15, 2009 08:41 AM Amylin (AMLN) Lilly (ELY) and Alkermes (ALKS) Announce Positive Results Comparing Exenatide to BYETTA

Sep 24, 2009 08:11 AM Alkermes (ALKS) Announces Amylin (AMLN) and Lilly (LLY) Will Present Over 20 Studies for Exenatide at EASD 2009

Jul 21, 2009 09:30 AM Amylin (AMLN) Announces Positive Results From Study Today

Jul 9, 2009 07:52 AM Amylin (AMLN) Reports Results from Dose-Ranging Study of Pramlintide/Metreleptin for Obesity

Jul 7, 2009 04:26 PM Amylin (AMLN), Eli Lilly (LLY), Alkermes (ALKS) Announce NDA for Exenatide Once Weekly Accepted for Review by FDA

Jun 8, 2009 05:36 PM Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta

Jun 2, 2009 12:42 PM Amylin (AMLN) Reports Preliminary Tabulation of Annual Meeting Results

May 27, 2009 03:36 PM Amylin (AMLN) Said No More Than Two Dissident Directors Elected

May 20, 2009 02:02 PM Amylin (AMLN) Issues Response to Eastbourne Letter

May 20, 2009 10:30 AM Icahn Urges Amylin (AMLN) Shareholders to Vote for Eastbourne Slate; 3 Independent Proxy Advisors Support Icahn's Nominees

May 14, 2009 09:47 AM Icahn Fires Back Following Amylin's (AMLN) Letter

May 11, 2009 05:08 PM Founding CEO of Amylin (AMLN), Greene, to Vote for Eastbourne Slate

May 5, 2009 08:07 AM Eli-Lilly (LLY), Amylin (AMLN), Alkermes (ALKS) File For A Once A Week Byetta

May 4, 2009 04:38 PM Amylin (AMLN) Changes Sales Structure, Cutting 35% Of Sales Force

May 1, 2009 10:09 AM Amylin (AMLN) Sends Letter to Shareholders

Apr 21, 2009 03:55 PM Icahn Sends Letter to Amylin's (AMLN) Cook, Wilson: Wouldn't Sell Co. for Less Than $30/Share

Apr 20, 2009 02:59 PM Icahn to Respond to Letter from Amylin (AMLN) -DJ

Apr 16, 2009 09:22 AM Amylin Pharmaceuticals (AMLN) And Eli Lilly (LLY) Amend Collaboration Agreement

Apr 15, 2009 10:50 AM Icahn Sends Letter to Amylin (AMLN): Demands Chairman's Resignation

Apr 3, 2009 01:31 PM Eastbourne Capital Sends Letter to Amylin (AMLN); Seeking 5 Seats on Board

Apr 3, 2009 11:07 AM Amylin (AMLN) Tumbles as Competitor to Byetta, Novo Nordisk's liraglutide, Does Not Receive FDA Recommendation

Mar 31, 2009 08:16 AM Amylin (AMLN), Eli Lilly (LLY), Alkermes (ALKS) Report Positive Results from DURATION-2 Study

Back to AMLN Stock Lookup